
|Videos|January 31, 2022
Increased financial coverage for Rezum therapy reaps benefits for patients with BPH
Author(s)Urology Times staff
“I think now the government has realized…the work that’s involved in this procedure…[and] we’re now being reimbursed at an appropriate level,” says David M. Albala, MD.
Advertisement
In this video, David M. Albala, MD, discusses how the recent change made by the Centers for Medicare & Medicaid Services regarding Rezum water vapor therapy will open the doors for more patients to receive this minimally invasive treatment. Albala is a urologist at Associate Medical Professionals and chief of urology at Crouse Hospital in Syracuse, New York.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












